Details
New companies 1 · Follow-on 0
Stages: Series B 1
Metagen Therapeutics ¥190M Series B extension (first close)Ranked by rounds participated in, from announcements in Jul 31, 2026 – Oct 28, 2026. Lead counts include only confirmed lead roles.
New companies 1 · Follow-on 0
Stages: Series B 1
Metagen Therapeutics ¥190M Series B extension (first close)New companies 1 · Follow-on 0
Stages: Series A 1
Business Nextgen Finance Private Limited ₹2.2B Series ANew companies 1 · Follow-on 0
Stages: Series A 1
Business Nextgen Finance Private Limited ₹2.2B Series A“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.